DEVELOPMENT OF ANTI-P185(HER2) IMMUNOLIPOSOMES FOR CANCER-THERAPY Article

PARK, JW, HONG, K, CARTER, P et al. (1995). DEVELOPMENT OF ANTI-P185(HER2) IMMUNOLIPOSOMES FOR CANCER-THERAPY . PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 92(5), 1327-1331. 10.1073/pnas.92.5.1327

Open Access Industry Collaboration

cited authors

  • PARK, JW; HONG, K; CARTER, P; ASGARI, H; GUO, LY; KELLER, GA; WIRTH, C; SHALABY, R; KOTTS, C; WOOD, WI; PAPAHADJOPOULOS, D; BENZ, CC

sustainable development goals

authors

publication date

  • February 28, 1995

published in

keywords

  • CELLS
  • ENDOCYTOSIS
  • EXPRESSION
  • HUMAN-BREAST
  • INVITRO
  • MONOCLONAL-ANTIBODY
  • Multidisciplinary Sciences
  • PHARMACOKINETICS
  • REVERSE-PHASE EVAPORATION
  • STERICALLY STABILIZED LIPOSOMES
  • Science & Technology
  • Science & Technology - Other Topics
  • VESICLES

Digital Object Identifier (DOI)

publisher

  • NATL ACAD SCIENCES

start page

  • 1327

end page

  • 1331

volume

  • 92

issue

  • 5